Perrigo Recalls Ranitidine Tablets Due to Potential N-Nitrosodimethylamine Contamination
Perrigo Company PLC is recalling Maximum Strength Acid Reducer, Ranitidine tablets, USP 150 mg, due to a CGMP deviation and possible contamination with the impurity N-nitrosodimethylamine.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The source text identifies the recall as FDA Class II and cites possible contamination with N-nitrosodimethylamine, a known carcinogen, which aligns with the rubric criteria for Severe severity involving significant health risks.
Plain-English summary
Perrigo Company PLC is recalling Maximum Strength Acid Reducer, Ranitidine tablets, USP 150 mg, 200 tablets per bottle. The recall involves specific lots of the product distributed nationwide in the United States. The affected NDCs include Basic Care (0113-7852-82), CVS Health (59779-540-82), HEB (37808-507-82), Signature Care (21130-116-82), and Walgreens (0363-0852-82).
The recall is being conducted due to a Current Good Manufacturing Practice (CGMP) deviation and the possibility of contamination with the impurity N-nitrosodimethylamine. The specific lot numbers affected are: 8AE1291, 8AE1785, 8BE1415, 8CE1525, 8DE1201, 8DE1741, 8EE1323, 8FE1806, 8GE1965, 8HE1517, 8JE2161, 8KE2565, 8LE2261, 8ME2548, 9AE2658, 9BE3018, 9CE3861, 9DE3244, 9FE2820, 9FE3373, 9GE3094, 9HE3449, and 9JE2665.
Consumers should check their bottles for the NDC and lot number listed above. If the product matches the recalled items, they should stop using it and contact their pharmacist or the recalling firm for instructions on return or disposal.
The recalled product
- Product
- Maximum Strength Acid Reducer, Ranitidine tablets, USP 150 mg, 200 tablets per bottle. [Brand, NDC] NDC Basic Care: 0113-7852-82; NDC CVS Health: 59779-540-82; NDC HEB: 37808-507-82; NDC Signature Care: 21130-116-82; NDC Walgreens: 0363-0852-82
- Manufacturer
- Perrigo Company PLC
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lots: 8AE1291
- 8AE1785
- 8BE1415
- 8CE1525
- 8DE1201
- 8DE1741
- 8EE1323
- 8FE1806
- 8GE1965
- 8HE1517
- 8JE2161
- 8KE2565
- 8LE2261
- 8ME2548
- 9AE2658
- 9BE3018
- 9CE3861
- 9DE3244
- 9FE2820
- 9FE3373
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 17 recalled by Perrigo Company PLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 17 products in this recall →Related recalls
Same manufacturer · Perrigo Company PLC
See all →- ModerateCareOne Severe Congestion Nasal Spray Recalled Due to Contaminated Excipient
FDA (Drugs) · 2022-03-02
- ModerateEquate Children's Pain and Fever Acetaminophen Suspension Recall
FDA (Drugs) · 2022-03-02
- ModerateEqualine Nasal Oxymetazoline HCl Nasal Spray Recalled for Contaminated Excipient
FDA (Drugs) · 2022-03-02
- ModerateUP AND UP Childrens Acetaminophen Recall Due to Contaminated Excipient
FDA (Drugs) · 2022-03-02
- ModerateCVS Infant's Grape Acetaminophen Suspension Recalled for Contaminated Excipient
FDA (Drugs) · 2022-03-02
Same hazard · nitrosamine contamination
See all →- SeverePerrigo Recalls Ranitidine Tablets Due to Potential N-Nitrosodimethylamine Contamination
FDA (Drugs) · 2020-03-25
- SeverePerrigo Recalls Ranitidine Tablets Due to Potential N-Nitrosodimethylamine Contamination
FDA (Drugs) · 2020-03-25
- SeverePerrigo Recalls Ranitidine Tablets Due to Potential N-Nitrosodimethylamine Contamination
FDA (Drugs) · 2020-03-25
- SeverePerrigo Recalls Ranitidine Tablets Due to Potential N-Nitrosodimethylamine Contamination
FDA (Drugs) · 2020-03-25
- SeverePerrigo Recalls Ranitidine Tablets Due to Possible N-Nitrosodimethylamine Contamination
FDA (Drugs) · 2020-03-25